Investor Information
| Stéphane Bette, Co founder and Deputy CEO |
Pierre Jérôme, Co founder, CEO & Chairman |
Dear Shareholders,
SpineGuard’s management invites you to a webinar to discuss the company’s news, to review its partnerships, and to present its innovations as well as its perspectives on November 10th at 10:30 am. Register now.
Stock Information
Stock exchange information
- ISIN code: FR0011464452
- Stock Quote: ALSGD
- Number of shares: 37.073.363
- Sector: Medical technologies
- Principal Index: Alternext All-share
- Exchange: Euronext-Growth
- Place of listing: Euronext Paris (France)
- Eligibility to French PEA/SRD: Yes/No
- Eligibility French PEA-PME: Yes
Financial agenda
- 9 January 2023: 2022 Full-Year Sales
- 13 April 2023: 2022 Full-Year Results
- 13 April 2023: 2023 First-Quarter Sales
- 8 June 2023: Annual Shareholders Meeting
- 11 July 2023: 2023 First-Half Sales
- 12 September 2023: 2023 First-Half Results
- 11 October 2023: 2023 Third-Quarter Sales
Analysts
- Biostrategic Research: Lionel Labourdette
Others
- Liquidity contract: Tradition Securities And Futures (TSAF)
- Auditors: Grant Thornton
- Listing Sponsor: Swiss Life Banque Privée
Shareholders structure
(December 31th, 2022)
Chart by Visualizer
Stock quotes
- To check the stock quote in real time, click here
For any request, don't hesitate to contact us
